Thanks to an in-utero treatment that's never been done before, Ottawa's Ayla Bashir is developing at a rate expected of the average 17-month-old infant — even while dealing with Pompe disease, a genetic disorder that killed two of her sisters.
A genetic disease killed Ayla's sisters. A first-of-its-kind treatment is helping her survive
Post a Comment